Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy
暂无分享,去创建一个
Puja K. Mehta | C. Merz | Jenna Dean | Sherwin Dela Cruz | C. Noel Bairey Merz | P. Mehta | Jenna Dean | S. D. Cruz
[1] H. Kucuk,et al. Association between microvascular angina and erectile dsyfunction , 2014, International Journal of Impotence Research.
[2] P. Puddu,et al. Comparison of verapamil versus propranolol therapy in syndrome X. , 1989, The American journal of cardiology.
[3] L. Opie. Calcium channel antagonists in the management of anginal syndromes: changing concepts in relation to the role of coronary vasospasm. , 1996, Progress in cardiovascular diseases.
[4] F. Crea,et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. , 2004, The American journal of cardiology.
[5] J. Kaski,et al. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. , 2003, Journal of the American College of Cardiology.
[6] Shing‐Jong Lin,et al. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. , 2002, The American journal of cardiology.
[7] Hsin-Chieh Yeh,et al. Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. , 2013, JAMA internal medicine.
[8] Carl J Pepine,et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. , 2010, Journal of the American College of Cardiology.
[9] S. Reis,et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. , 2005, European heart journal.
[10] M. Kinoshita,et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the right coronary artery by transthoracic Doppler echocardiography: comparison with intracoronary Doppler guidewire. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[11] P. Spinhoven,et al. Cognitive-behavioral therapy for noncardiac chest pain: a randomized trial. , 1999, The American journal of medicine.
[12] E. Ernst,et al. Autogenic training to manage symptomology in women with chest pain and normal coronary arteries , 2009, Menopause.
[13] J. Shryock,et al. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine , 2006, Heart.
[14] J. Michel,et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. , 1994, The American journal of physiology.
[15] D. Cokkinos,et al. Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. , 1999, The American journal of cardiology.
[16] W. Laskey,et al. Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. , 2002, American heart journal.
[17] W L Maughan,et al. Comparison of continuous left ventricular volumes by transthoracic two-dimensional digital echo quantification with simultaneous conductance catheter measurements in patients with cardiac diseases. , 1997, The American journal of cardiology.
[18] F. Crea,et al. Coronary microvascular dysfunction. , 2013, The New England journal of medicine.
[19] B. Chow,et al. Cardiac PET: metabolic and functional imaging of the myocardium. , 2013, Seminars in nuclear medicine.
[20] L. Shaw,et al. Cost-effectiveness of myocardial perfusion imaging: A summary of the currently available literature , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[21] L. Vignati,et al. Diabetic microvascular complications--can the presence of one predict the development of another? , 2006, Journal of diabetes and its complications.
[22] A. Jaffe,et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[23] Jennifer G. Robinson,et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[24] B. Gersh,et al. ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .
[25] J. Zamorano,et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. , 1996, European heart journal.
[26] Sonia S. Anand,et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. , 2008, European heart journal.
[27] Christopher M Kramer,et al. Coronary microvascular dysfunction in women: an overview of diagnostic strategies , 2013, Expert review of cardiovascular therapy.
[28] Carl J Pepine,et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. , 2006, Journal of the American College of Cardiology.
[29] Dudley J Pennell,et al. Adjunctive role of cardiovascular magnetic resonance in the assessment of patients with inferior attenuation on myocardial perfusion SPECT. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[30] Henrik Vestergaard,et al. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. , 2004, Archives of internal medicine.
[31] M. Emdin,et al. Improved exercise capacity with acute aminophylline administration in patients with syndrome X. , 1989, Journal of the American College of Cardiology.
[32] H. Hemingway,et al. Incidence and Prognostic Implications of Stable Angina Pectoris Among Women and Men , 2006, JAMA.
[33] Carl J Pepine,et al. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. , 2013, American heart journal.
[34] T. Lüscher,et al. Structure and reactivity of small arteries in aging. , 1998, Cardiovascular research.
[35] A. Quyyumi,et al. Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation. , 2014, American heart journal.
[36] K. Smith,et al. Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results From the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.
[37] R. Cannon,et al. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. , 1985, The American journal of cardiology.
[38] L. Shaw,et al. Signs and symptoms of suspected myocardial ischemia in women: results from the What is the Optimal Method for Ischemia Evaluation in WomeN? Trial. , 2011, Journal of women's health.
[39] O. Rimoldi,et al. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. , 2013, JACC. Cardiovascular imaging.
[40] A. Hughes,et al. Attenuated Systemic Microvascular Function in Men with Coronary Artery Disease is Associated with Angina but not Explained by Atherosclerosis , 2013, Microcirculation.
[41] O. Hess,et al. Does the β-Blocker Nebivolol Increase Coronary Flow Reserve? , 2007, Cardiovascular Drugs and Therapy.
[42] K. Fox,et al. Chest pain in women: clinical, investigative, and prognostic features , 1994, BMJ.
[43] S. Reis,et al. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) , 2007, Clinical cardiology.
[44] E. Agabiti-Rosei. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy]. , 2003, Drugs.
[45] B. Chaitman,et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. , 2005, Journal of the American College of Cardiology.
[46] M. Chang,et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. , 1997, The American journal of cardiology.
[47] M. Schwaiger,et al. Gender differences in myocardial blood flow dynamics: lipid profile and hemodynamic effects. , 1999, Journal of the American College of Cardiology.
[48] B. Lindahl,et al. Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender. , 2014, American heart journal.
[49] C. Pepine. Ischemic heart disease in women: facts and wishful thinking. , 2004, Journal of the American College of Cardiology.
[50] L. Lerman,et al. Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses , 2014, Coronary artery disease.
[51] 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina , 2007 .
[52] Juhani Knuuti,et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. , 2013, Journal of the American College of Cardiology.
[53] K. Johnson. An Update. , 1984, Journal of food protection.
[54] S. Reis,et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. , 2006, Journal of the American College of Cardiology.
[55] M. Okano,et al. Cohort Study , 2020, Definitions.
[56] Min Gao,et al. Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. , 2013, American heart journal.
[57] S. Novo,et al. Diagnosi di disfunzione del microcircolo coronarico in pazienti diabetici con sindrome X cardiaca: confronto tra le metodiche attualmente in uso , 2013 .
[58] A. Dogan,et al. Effects of nebivolol therapy on endothelial functions in cardiac syndrome X , 2010, Heart and Vessels.
[59] E. Jones,et al. Cardiac syndrome X and microvascular coronary dysfunction. , 2012, Trends in cardiovascular medicine.
[60] L. Shaw,et al. Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.
[61] O. Pachinger,et al. Sex differences in independent factors associated with coronary artery disease , 2014, Wiener klinische Wochenschrift.
[62] Amit R. Patel,et al. Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance , 2013, Journal of Cardiovascular Magnetic Resonance.
[63] Vasken Dilsizian,et al. Quantitative PET/CT Measures of Myocardial Flow Reserve and Atherosclerosis for Cardiac Risk Assessment and Predicting Adverse Patient Outcomes , 2013, Current Cardiology Reports.
[64] Enrico Agabiti-Rosei. Modifications structurelles et fonctionnelles de la microcirculation dans l’hypertension: Influence du traitement pharmacologique , 2003 .
[65] M. Budoff,et al. Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients. , 2012, JACC. Cardiovascular imaging.
[66] L. Lerman,et al. Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[67] W. Weintraub,et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.
[68] Erik Jørgensen,et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.
[69] P. Albertsson,et al. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. , 1996, International journal of cardiology.
[70] R. Erbel,et al. Noninvasive assessment of microvascular function in arterial hypertension by transthoracic Doppler harmonic echocardiography. , 2002, Journal of the American College of Cardiology.
[71] B. Chaitman,et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. , 2004, JAMA.
[72] D. Vido,et al. Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. , 2013, Journal of women's health.
[73] Daniel S Berman,et al. Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. , 2013, Cardiovascular diagnosis and therapy.
[74] Natesa G. Pandian,et al. Myocardial Perfusion Imaging Using Contrast Echocardiography , 2002, Herz.
[75] B. Chaitman,et al. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials. , 2007, The American journal of cardiology.
[76] Rowena J Dolor,et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.
[77] P. Colonna,et al. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography. , 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.
[78] J. Kaski,et al. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. , 2012, European heart journal.
[79] K. Ogbonnaya,et al. Pathophysiology, Diagnosis, and Management , 2017 .
[80] K. Smith,et al. Some thoughts on the vasculopathy of women with ischemic heart disease. , 2006, Journal of the American College of Cardiology.
[81] A M Zeiher,et al. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.
[82] S. Iliceto,et al. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire. , 1999, Journal of the American College of Cardiology.
[83] F. Crea,et al. Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management , 2010, Circulation.
[84] Jeroen J. Bax,et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.
[85] H. Bøtker,et al. Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X. , 1998, The American journal of cardiology.
[86] G. de Simone,et al. Coronary flow reserve in hypertensive patients with hypercholesterolemia and without coronary heart disease. , 2007, American journal of hypertension.
[87] Chang Mau-Song,et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina , 1997 .
[88] F. Crea,et al. Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .
[89] R. Blankstein,et al. Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization , 2015, Circulation.
[90] C Noel Bairey Merz,et al. Angina with "normal" coronary arteries. , 2005 .
[91] C. Noel Bairey Merz,et al. Women and ischemic heart disease: evolving knowledge. , 2009, Journal of the American College of Cardiology.
[92] L. Shaw,et al. Impact of Ethnicity and Gender Differences on Angiographic Coronary Artery Disease Prevalence and In-Hospital Mortality in the American College of Cardiology–National Cardiovascular Data Registry , 2008, Circulation.
[93] O. Alfieri,et al. Immediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris. , 2003, The American journal of cardiology.
[94] F. Crea,et al. Effect of spinal cord stimulation on spontaneous and stress-induced angina and 'ischemia-like' ST-segment depression in patients with cardiac syndrome X. , 2005, European heart journal.
[95] Piotr J Slomka,et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. , 2011, JACC. Cardiovascular imaging.
[96] A. Yeung,et al. Comparison of Coronary Thermodilution and Doppler Velocity for Assessing Coronary Flow Reserve , 2003, Circulation.
[97] F. Crea,et al. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. , 2013, The American journal of cardiology.
[98] S. Reis,et al. Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: Results from the nhlbi wise study , 2002, Clinical cardiology.
[99] Basmah Safdar,et al. Gender-specific research for emergency diagnosis and management of ischemic heart disease: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup. , 2014, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[100] C. N. Bairey Merz,et al. Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation Study , 2015 .
[101] S. Denardo,et al. Effect of Phosphodiesterase Type 5 Inhibition on Microvascular Coronary Dysfunction in Women: A Women's Ischemia Syndrome Evaluation (WISE) Ancillary Study , 2011, Clinical cardiology.
[102] K. Schenck-Gustafsson,et al. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? , 2011, European heart journal.
[103] K. Smith,et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia , 2011, American heart journal.
[104] U. Thadani. Current Medical Management of Chronic Stable Angina , 2004, Journal of cardiovascular pharmacology and therapeutics.
[105] Mark Woodward,et al. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies , 2011, The Lancet.
[106] P. Puddu,et al. Assessment of flow velocity reserve by transthoracic Doppler echocardiography and venous adenosine infusion before and after left anterior descending coronary artery stenting. , 2001, Journal of the American College of Cardiology.
[107] S. Higano,et al. Abnormal coronary microvascular endothelial function in humans with asymptomatic left ventricular dysfunction. , 2003, American heart journal.
[108] F. Rank,et al. PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE , 2000 .
[109] J. Kaski,et al. Mechanisms of Angina Pectoris in Syndrome , 2016 .
[110] L. Pilote,et al. Angina with "normal" coronary arteries: sex differences in outcomes. , 2008, American heart journal.
[111] F. Crea,et al. Mechanisms of angina pectoris in syndrome X. , 1991, Journal of the American College of Cardiology.
[112] Kamlesh Kothawade,et al. Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. , 2011, Current problems in cardiology.
[113] Michael C. Petch,et al. Effect of Transcutaneous Electrical Nerve Stimulation on Coronary Blood Flow , 1994, Circulation.
[114] K. McDonald,et al. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. , 2000, JAMA.
[115] I. Chetter,et al. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials. , 2011, Atherosclerosis.
[116] P. Vardas,et al. Ivabradine improves coronary flow reserve in patients with stable coronary artery disease. , 2011, Atherosclerosis.
[117] K. McDonald,et al. Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina , 1999 .
[118] Faha,et al. Aha Guideline Effectiveness-based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update a Guideline from the American Heart Association Executive Writing Committee Expert Panel Members Cvd Risk Assessment Table 1. Class Iii Interventions (not Useful/effective and May Be Harmfu , 2022 .
[119] H. Gullu,et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. , 2008, Atherosclerosis.
[120] Carl J Pepine,et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.
[121] Pawe,et al. Transthoracic Doppler echocardiography – noninvasive diagnostic window for coronary flow reserve assessment , 2003, Cardiovascular ultrasound.
[122] P. Rothwell,et al. Meta-analysis of randomised controlled trials , 1997, The Lancet.
[123] B. Chaitman,et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. , 1995, Journal of the American College of Cardiology.
[124] B. Chaitman,et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. , 2004, Journal of the American College of Cardiology.
[125] Werner Jaschke,et al. The diagnostic and prognostic value of coronary CT angiography in asymptomatic high-risk patients: a cohort study , 2014, Open Heart.
[126] B. Strauer,et al. Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy , 1997, Virchows Archiv.
[127] J. Balligand,et al. Cardiomyocyte-specific overexpression of beta3-adrenoceptors attenuates the hypertrophic response to catecholamines in vivo , 2007 .
[128] B. Chaitman,et al. Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes. , 2006, European heart journal.
[129] R. Kwong,et al. Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes , 2014, Diabetes.
[130] R. Blankstein,et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. , 2012, JACC Cardiovascular Imaging.
[131] S. Martino,et al. Safety assessment of raloxifene over eight years in a clinical trial setting* , 2005, Current medical research and opinion.
[132] G S Weinstein,et al. Coronary artery surgery study. , 1985, The American journal of cardiology.
[133] J. Kaski,et al. Cardiac syndrome X in women: the role of oestrogen deficiency , 2006, Heart.
[134] Eric Vicaut,et al. Platelet function testing to adjust antiplatelet therapy for elective coronary stenting: a landmark analysis of the ARCTIC trial , 2013 .
[135] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[136] J. Kastrup,et al. Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale. , 2014, American heart journal.
[137] O. Hess,et al. Does the beta-blocker nebivolol increase coronary flow reserve? , 2007, Cardiovascular drugs and therapy.
[138] Onathan R. P Anting,et al. ABNORMAL SUBENDOCARDIAL PERFUSION IN CARDIAC SYNDROME X DETECTED BY CARDIOVASCULAR MAGNETIC RESONANCE IMAGING , 2002 .
[139] P. Ridker,et al. Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) , 2010, Circulation.
[140] S. Reis,et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. , 2008, The Journal of clinical endocrinology and metabolism.
[141] L. Shaw,et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. , 2012, JACC. Cardiovascular interventions.
[142] K. Smith,et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). , 2010, Journal of interventional cardiology.
[143] J. Kaski,et al. Coronary microvascular spasm triggers transient ischemic left ventricular diastolic abnormalities in patients with chest pain and angiographically normal coronary arteries. , 2014, Atherosclerosis.
[144] Pepine,et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. , 2001, American heart journal.
[145] P. Mehta,et al. Treatment of Angina and Microvascular Coronary Dysfunction , 2010, Current treatment options in cardiovascular medicine.
[146] D. Berman,et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. , 2011, JACC. Cardiovascular imaging.
[147] E. Barrett-Connor,et al. Adult Weight Change and Risk of Postmenopausal Breast Cancer , 2006, The New England journal of medicine.
[148] S. Kelsey,et al. Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored WISE Study , 2014, Journal of the American Heart Association.
[149] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[150] C. Tribouilloy,et al. Transthoracic coronary flow velocity reserve assessment: comparison between adenosine and dobutamine. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[151] E. Porteri,et al. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. , 2003, Journal of hypertension.
[152] Ornella Rimoldi,et al. Coronary microvascular dysfunction: mechanisms and functional assessment , 2015, Nature Reviews Cardiology.
[153] Eloise E Kaizar,et al. Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study. , 2006, Journal of women's health.
[154] S. Kelsey,et al. A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). , 2010, American heart journal.
[155] P. Poole‐Wilson,et al. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. , 1996, Journal of the American College of Cardiology.
[156] R Smith. Conflict of interest and the BMJ , 1994, BMJ.
[157] J. Heo,et al. Impact of stress single-photon emission computed tomography perfusion imaging on downstream resource utilization. , 1999, American Journal of Cardiology.
[158] J. Rumsfeld,et al. Utilization of Secondary Prevention Therapies in Patients With Nonobstructive Coronary Artery Disease Identified During Cardiac Catheterization: Insights From the National Cardiovascular Data Registry Cath-PCI Registry , 2010, Circulation. Cardiovascular quality and outcomes.
[159] W. Lawson,et al. Enhanced external counterpulsation is an effective treatment for Syndrome X. , 2009, International journal of cardiology.
[160] E. Morse,et al. Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction , 2015 .
[161] C. Webb,et al. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms , 2001, Menopause.
[162] O. Rimoldi,et al. Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes , 2014, Circulation.
[163] I. Harris,et al. A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010 .
[164] A. Sanabria,et al. Randomized controlled trial. , 2005, World journal of surgery.
[165] A. Khera,et al. Angina in Women without Obstructive Coronary Artery Disease , 2009, Current cardiology reviews.
[166] M. C. S. Solano Ruiz,et al. Ischemic heart disease in women. , 2011, Revista latino-americana de enfermagem.
[167] R. Blankstein,et al. Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease , 2015, Circulation.
[168] K. Shimada,et al. Prognostic value of coronary flow reserve on long-term cardiovascular outcomes in patients with chronic kidney disease. , 2013, The American journal of cardiology.
[169] M. D. Di Carli,et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. , 2003, Journal of the American College of Cardiology.
[170] S. Kelsey,et al. TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) , 2014, PloS one.
[171] Amir Lerman,et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[172] P. Libby,et al. Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). , 2010, The American journal of cardiology.
[173] A. Maseri,et al. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. , 1999, The American journal of cardiology.